FOLLOWING UP A METAL SEQUESTERING THERAPY BY GRAPHITE FURNACE ATOMIC ABSORPTION SPECTROMETRY

Removal of aluminum, copper, zinc, iron and lead was monitored by using graphite furnace atomic absorption spectrometry (GFAAS), in five renal patients undergoing peritoneal dialysis and receiving a chelation therapy with desferrioxamine B. Aluminum losses were between 0.3 and 6.7mg; mean removal of...

Full description

Saved in:
Bibliographic Details
Published in:Analytical Sciences 1991, Vol.7(Supple), pp.837-840
Main Authors: ROMERO, ROMER A., NAVARRO, JANETH A., GRANADILLO, VICTOR A.
Format: Article
Language:English
Subjects:
desferrioxamine B
graphite furnace atomic absorption spectrometry
peritoneal dialysis
whole blood metals
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Removal of aluminum, copper, zinc, iron and lead was monitored by using graphite furnace atomic absorption spectrometry (GFAAS), in five renal patients undergoing peritoneal dialysis and receiving a chelation therapy with desferrioxamine B. Aluminum losses were between 0.3 and 6.7mg; mean removal of 42±5μg Pb was obtained. Copper, zinc and iron were not significantly affected. GFAAS proved to be useful to follow up metal changes in humans.
ISSN:0910-6340
1348-2246
DOI:10.2116/analsci.7.Supple_837